JNJ JOHNSON & JOHNSON Earnings Reports 8-K Filing 2025 - Earnings Report Johnson & Johnson reported a quarterly earnings increase of 5% year-over-year, with total revenue reaching $23 billion, driven by strong sales in its pharmaceutical division.Get access to all SEC 8-K filings of the JOHNSON & JOHNSON